Cargando…
Clinical course and seroprevalence of COVID-19 in children with rheumatic diseases—cross-sectional study from a reference centre in Spain
SARS-CoV-2 infections in children are frequently asymptomatic or mild and can go unnoticed. This study aimed to describe the seroprevalence and clinical course of SARS-CoV-2 in a cohort of children with rheumatic diseases in a real-life setting and assess possible risk factors. A cross-sectional stu...
Autores principales: | Udaondo, Clara, Millán-Longo, Claudia, Permuy, Celia, Valladares, Laura, Falces-Romero, Iker, Muñoz-Gómez, Celia, Morales-Higuera, Mónica, Alcobendas, Rosa, Remesal, Agustín, Murias, Sara, Calvo, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055001/ https://www.ncbi.nlm.nih.gov/pubmed/35489011 http://dx.doi.org/10.1007/s10067-022-06186-z |
Ejemplares similares
-
Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases
por: Udaondo, Clara, et al.
Publicado: (2022) -
Colchicine treatment in children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: A multicenter study in Spain
por: Quintana-Ortega, Cristian, et al.
Publicado: (2021) -
Severe Thrombocytopenia as the Main Manifestation of Childhood-Onset Systemic Lupus Erythematosus
por: Quintana-Ortega, Cristian, et al.
Publicado: (2022) -
Clinical manifestations of four patients diagnosed with early-onset sarcoidosis or sarcoid-like syndrome
por: Murias, Sara, et al.
Publicado: (2014) -
PReS-FINAL-2274: Antiadalimumab antibodies in pediatric rheumatology patients. A pilot experience
por: Murias Loza, S, et al.
Publicado: (2013)